Correction: Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior (Cancers, (2021), 13, 24, (6256), 10.3390/cancers13246256)
Academic Article in Scopus
In the original publication [1], several minor textual and tabular transcription issues and an ambiguous phrasing were identified in Sections 2.4, 2.7, and 3.2. The corrected text appears below. The sentence ¿All 68 samples were inserted into the algorithm, which classified 55 samples into one of the aforementioned subtypes; in total, 11 samples were labeled as unclassified.¿ has been corrected to ¿All 68 samples were inserted into the algorithm, which classified 55 samples into one of the aforementioned subtypes; in total, 13 samples were labeled as unclassified.¿ The software attribution ¿R statistical software version 4.1.1 (GPL Technologies, Burbank, CA, USA)¿ has been corrected to ¿R statistical software version 4.1.1 (R Core Team, Vienna, Austria)¿. The sentence ¿Out of the cohort of 57 patients with clinical stage III disease, 70.2% did not respond to treatment.¿ has been corrected to ¿Out of the cohort of 57 patients with clinical stage III disease, 40 (70.2%) had at least one high-risk pathological feature (positive axillary lymph nodes, histologic grade 3, Ki-67 index > 20% or lymphovascular invasion)¿. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
